Searched for
VENUS PHARMA GMBH
Venus Remedies eyes $15 million from antibiotic meropenem; ties up with drug maker-MylanDeal with Mylan will enable Venus to market meropenem in Denmark, Sweden & Finland for a period of five years with estimated revenue of $1....08 Sep, 2014, 06.46 PM IST- Venus eyes $ 15 million from meropenem; ties up with MylanCurrently, Panchkula based drug major is selling meropenem in 35 countries which also includes regulated markets with revenue of $ 10 milli...08 Sep, 2014, 05.52 PM IST
- Venus Remedies shares up as unit enters into pact with MylanIn terms of volume, 3.14 lakh shares of the company changed hands at the BSE, while over 11 lakh shares were traded at the NSE during the d...08 Sep, 2014, 05.16 PM IST
- Venus Pharma ties up with Mylan for marketing of antibiotic MeropenemThe deal with Mylan will enable Venus Remedies to market meropenem in Denmark, Sweden and Finland for a period of five years.08 Sep, 2014, 01.33 PM IST
- Venus Remedies rallies on getting marketing approval in SwitzerlandThe marketing approval for Gemcitabine will help the company further strengthen its oncology portfolio and improve its presence in this spa...21 Aug, 2014, 09.46 AM IST
- India based Venus Remedies gets market authorisation for oncology drugs from Swiss authorityChandigarh based pharma company Venus Remedies gets green signal for maket authorisation of oncology drugs from Swiss drug authority20 Aug, 2014, 04.52 PM IST
- Venus Pharma gets marketing authorisation nod from FranceVenus Pharma GmbH said it has got marketing authorisation (MA) approval from France for meropenem, a generic broad spectrum antibiotic inje...20 Aug, 2013, 05.22 PM IST
- Venus Remedies' Baddi unit gets Syria approvalVenus Remedies' manufacturing unit at Baddi has received approval from General Foreign Trade Organization of Syria to manufacture and expor...31 Mar, 2008, 10.29 AM IST
Load More
